PERBELLINI, RICCARDO

PERBELLINI, RICCARDO  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 18 di 18 (tempo di esecuzione: 0.017 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
High Rate of Antibody Response to Multiple Doses of the COVID-19 Vaccine in Liver Transplant Recipients: Analysis of Predictive Factors 2025 Nunzio ZignaniAndrea CostantinoClara DibenedettoRiccardo PerbelliniSara Uceda RenteriaPietro Lampertico + Article (author) -
Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis delta 2024 Degasperi, ElisabettaTestoni, BarbaraRenteria, Sara UcedaAnolli, Maria PaolaFacchetti, FlorianaPerbellini, RiccardoCallegaro, AnnapaolaLampertico, Pietro + Article (author) -
Quantification of serum HDV RNA by Robogene 2.0 in HDV patients is significantly influenced by the extraction methods 2024 Anolli, Maria PaolaRenteria, Sara UcedaDegasperi, ElisabettaBorghi, MartaFacchetti, FlorianaPerbellini, RiccardoLampertico, Pietro + Article (author) -
Sodium taurocholate cotransporting polypeptide (NTCP) polymorphisms may influence HDV RNA load and early response to bulevirtide 2024 Degasperi, ElisabettaAnolli, Maria PaolaFacchetti, FlorianaBorghi, MartaPerbellini, RiccardoLampertico, Pietro + Article (author) -
Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension 2022 Degasperi EAnolli MPUceda Renteria SCPerbellini RFacchetti FLoglio ACostantino ALampertico P. + Article (author) -
Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVR 2022 Degasperi EAnolli MPFanetti ISoffredini RIavarone MTosetti GPerbellini RSangiovanni ALampertico P. + Article (author) -
Safety and effectiveness of up to 3 years' bulevirtide monotherapy in patients with HDV-related cirrhosis 2022 Loglio AUceda Renteria SCPerbellini RRimondi AFarina ETrombetta EManunta MLampertico P. + Article (author) -
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 2021 Lombardi A.Colaneri M.D'Ambrosio R.Degasperi E.Dibenedetto C.Giorgini A.Pasulo L.Spinelli O.Re T.Rumi M.Aghemo A.Lampertico P.Soffredini R.Perbellini R.Gori A.Colpani M.Manini M.Lazzaroni S.De Nicola S.Angelini Zucchetti T.Rossotti R.Colella E.Magnani C.Mena M.Caramma I.Basilico C.Biagiotti S.Mazzone A.Saladino V.Menzaghi B.Rumi M.Fanetti I.Dibenedetto C.Zermiani P.Zuin M.D'Arminio Monforte A.Capretti A.Messina E.Colombo A. E.Bonfanti P.Conforti S.Menozzi F.Gritti S.Giani P. + Article (author) -
A new algorithm shows superior ability to discriminate liver fibrosis stages in chronic hepatitis C 2021 D'Ambrosio, RobertaPerbellini, RiccardoLombardi, AndreaLampertico, Pietro + Article (author) -
The relationship between liver histology and thyroid function tests in patients with nonalcoholic fatty liver disease (NAFLD) 2021 D'Ambrosio R.Campi I.Perbellini R.Stucchi R.Degasperi E.De Silvestri A.Persani L.Fugazzola L.Lampertico P. + Article (author) -
The combination of PIVKA-II and AFP improves the detection accuracy for HCC in HBV caucasian cirrhotics on long-term oral therapy 2020 Loglio A.Iavarone M.Facchetti F.Di Paolo D.Perbellini R.Lampertico P. + Article (author) -
Hepatic Fat-Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAs 2020 Degasperi, ElisabettaGalmozzi, EnricoPelusi, SerenaD'Ambrosio, RobertaSoffredini, RobertaPerbellini, RiccardoFacchetti, FlorianaIavarone, MassimoValenti, LucaLampertico, Pietro + Article (author) -
Changes in bone mineral density during monotherapy with tenofovir disoproxil fumarate: a 6-year real life longitudinal cohort study in chronic hepatitis B caucasian patients 2020 Loglio, A.Cerini, F.Farina, E.Facchetti, F.Perbellini, R.Rumi, M. G.Lampertico, P. + Article (author) -
Excellent safety and effectiveness of high-dose myrcludex-B monotherapy administered for 48 weeks in HDV-related compensated cirrhosis : a case report of 3 patients 2019 Loglio A.Perbellini R.Giovanelli S.Lampertico P. + Article (author) -
12 weeks ombitasvir/paritaprevir-ritonavir + ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosis 2018 E. DegasperiR. D'AmbrosioR. PerbelliniS. De NicolaP. Lampertico + Article (author) -
Persistence of hepatocellular carcinoma risk in hepatitis C patients with a response to IFN and cirrhosis regression 2018 R. D'AmbrosioM. G. RumiE. DegasperiR. PerbelliniP. Lampertico + Article (author) -
I MICRORNA NELLE DISTROFIE MIOTONICHE 2010 PERBELLINI, RICCARDO Doctoral Thesis -
Determination of urinary 2,5-hexanedione in the general Italian population 1998 BALDUCCI, LUCAP. DucaL. PerbelliniPERICO, LAURAC. Minoia + Article (author) -